A systematic review suggested increased circulating nesfatin concentrations in people with a recent T2D diagnosis; in contrast, they were found to be lower than healthy controls in patients with T2D receiving glucose-lower treatment [23]. Here, NUCB2 is linked to type 2 diabetes mellitus.